表紙
市場調査レポート

米国における肩関節および小関節再建市場の見通し

United States Shoulder Reconstruction and Small Joints Market Outlook to 2021

発行 GlobalData 商品コード 297035
出版日 ページ情報 英文 118 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.18円で換算しております。
Back to Top
米国における肩関節および小関節再建市場の見通し United States Shoulder Reconstruction and Small Joints Market Outlook to 2021
出版日: 2015年09月11日 ページ情報: 英文 118 Pages
概要

当レポートでは、米国における肩関節および小関節再建市場について、肩関節、指関節、肘関節、足および手首関節再建のカテゴリー別売上、販売数の実績および予測、平均価格、企業シェア、流通シェア、主要企業のプロファイル、パイプライン製品、主な財務取引についての最新情報などを提供しまとめており、概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクション

  • レポートの内容
  • 肩関節および小関節再建市場の区分
  • 本レポートで対象としている市場の定義

第3章 米国における肩関節および小関節再建市場

  • 収益(実績)
  • 収益(予測)
  • 販売数(実績)
  • 販売数(予測)
  • 平均価格
  • 流通シェア:収益別
  • 企業シェア:収益別

第4章 主要企業の概要

  • DePuy Companies
  • Biomet, Inc
  • Zimmer Holdings, Inc.
  • Tornier N.V.
  • Wright Medical Group, Inc.
  • Exactech, Inc.
  • Stryker Corporation
  • Smith. Nephew Plc
  • Small Bone Innovations, Inc.
  • DJO Finance LLC
  • Ascension Orthopedics, Inc.

第5章 パイプライン製品

第6章 財務取引の情勢

  • 資本取引
  • 私募債発行
  • 株式売出
  • 提携
  • プライベートエクイティ
  • ベンチャー資金調達

第7章 最近の動向

  • 企業通信
  • 財務発表
  • 政府および世論の関心
  • 法規制
  • 製品情報
  • 戦略および事業計画

第8章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDMECC1024DB

GlobalData's new report, "United States Shoulder Reconstruction and Small Joints Market Outlook to 2021", provides key market data on the United States Shoulder Reconstruction and Small Joints market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments - Shoulder Replacement, Ankle Replacement, Elbow Replacement , Digits Replacement and Wrist Replacement.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Shoulder Reconstruction and Small Joints market categories - Shoulder Replacement, Ankle Replacement, Elbow Replacement , Digits Replacement and Wrist Replacement.
  • Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Shoulder Reconstruction and Small Joints market.
  • Global corporate-level profiles of key companies operating within the United States Shoulder Reconstruction and Small Joints market.
  • Key players covered include DePuy Companies, Tornier N.V., Zimmer Holdings, Inc., Biomet, Inc., Smith & Nephew Plc, Stryker Corporation, DJO Finance LLC and Small Bone Innovations, Inc.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Shoulder Reconstruction and Small Joints Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Shoulder Reconstruction and Small Joints Market, United States

  • 3.1. Shoulder Reconstruction and Small Joints Market, United States, Revenue ($m), 2007-2014
  • 3.2. Shoulder Reconstruction and Small Joints Market, United States, Revenue ($m), 2014-2021
    • 3.2.1. Elbow Replacement Market, United States, Revenue ($m), by Segment, 2007-2014
    • 3.2.2. Shoulder Replacement Market, United States, Revenue ($m), by Segment, 2007-2014
    • 3.2.3. Elbow Replacement Market, United States, Revenue ($m), by Segment, 2014-2021
    • 3.2.4. Shoulder Replacement Market, United States, Revenue ($m), by Segment, 2014-2021
  • 3.3. Shoulder Reconstruction and Small Joints Market, United States, Volume (Units), 2007-2014
  • 3.4. Shoulder Reconstruction and Small Joints Market, United States, Volume (Units), 2014-2021
    • 3.4.1. Elbow Replacement Market, United States, Volume (Units), by Segment, 2007-2014
    • 3.4.2. Shoulder Replacement Market, United States, Volume (Units), by Segment, 2007-2014
    • 3.4.3. Elbow Replacement Market, United States, Volume (Units), by Segment, 2014-2021
    • 3.4.4. Shoulder Replacement Market, United States, Volume (Units), by Segment, 2014-2021
  • 3.5. Shoulder Reconstruction and Small Joints Market, United States, Average Price ($), 2007-2021
  • 3.6. Shoulder Reconstruction and Small Joints Market, United States, Distribution Share by Revenue ($m), 2013-2014
  • 3.7. Shoulder Reconstruction and Small Joints Market, United States, Company Share by Revenue ($m), 2014

4. Overview of Key Companies in United States, Shoulder Reconstruction and Small Joints Market

  • 4.1. Zimmer Biomet Holdings, Inc.
    • 4.1.1. Company Overview
  • 4.2. DePuy Companies
    • 4.2.1. Company Overview
  • 4.3. Stryker Corporation
    • 4.3.1. Company Overview
  • 4.4. Tornier N.V.
    • 4.4.1. Company Overview
  • 4.5. Biomet, Inc. (Inactive)
    • 4.5.1. Company Overview
  • 4.6. Exactech, Inc.
    • 4.6.1. Company Overview
  • 4.7. Limacorporate S.p.a.
    • 4.7.1. Company Overview
  • 4.8. Wright Medical Group, Inc.
    • 4.8.1. Company Overview
  • 4.9. DJO Finance LLC
    • 4.9.1. Company Overview
  • 4.10. Integra LifeSciences Holdings Corporation
    • 4.10.1. Company Overview
  • 4.11. Corin Group Plc
    • 4.11.1. Company Overview

5. Shoulder Reconstruction and Small Joints Market Pipeline Products

6. Financial Deals Landscape

  • 6.1. Acquisition
    • 6.1.1. Hill-Rom to Acquire Welch Allyn for USD2.05 Billion
  • 6.2. Asset Transactions
    • 6.2.1. Smith & Nephew to Acquire Zimmer Unicompartmental High Flex Knee System Rights in the US
  • 6.3. Equity Offerings
    • 6.3.1. Histogenics Prices IPO for USD65 Million
  • 6.4. Merger
    • 6.4.1. Wright Medical to Merge with Tornier
  • 6.5. Venture Financing
    • 6.5.1. Cartiva Raises Additional USD2.5 Million in Series D Financing
    • 6.5.2. Zyga Raises USD2 Million in Series C-3 Financing
    • 6.5.3. OrthAlign Raises USD15 Million in Venture Financing
    • 6.5.4. Blue Belt Secures USD40 Million From CRG
    • 6.5.5. Zyga Raises USD2 Million in Series D Venture Financing
    • 6.5.6. Orthopaedic Synergy Raises Additional USD0.9 Million in Venture Financing

7. Recent Developments

  • 7.1. Corporate Communications
    • 7.1.1. Jul 30, 2015: Histogenics Announces Appointment of Stephen Kennedy to Chief Technology Officer
    • 7.1.2. Jul 15, 2015: Histogenics Announces Dr. Gloria Matthews as Chief Medical Officer
    • 7.1.3. Jul 07, 2015: Interventional Spine Appoints Joseph G. Darling, Vice President and Chief Operating Officer
    • 7.1.4. Jun 22, 2015: Histogenics Announces Appointment of New Chief Financial Officer
    • 7.1.5. May 11, 2015: Histogenics Announces World Class Scientific Advisory Board to Support Commercialization and Pipeline Development
    • 7.1.6. Feb 25, 2015: NuOrtho Surgical Files For Chapter 7 Bankruptcy
    • 7.1.7. Feb 02, 2015: Histogenics Announces the Appointment of David Gill to Its Board of Directors and Chairman of Audit Committee
    • 7.1.8. Jan 07, 2015: Patient Enrollment Complete for NF-?B Decoy Oligo Coated PTA Balloon Catheter Clinical Trials for Hemodialysis Shunts
    • 7.1.9. Dec 15, 2014: Vilex Appoints Jeff Segert as Vice President of Sales
    • 7.1.10. Nov 24, 2014: High-Dose Interleukin-2 Effective In mRCC Pre-Treated With VEGF-Targeted Therapies
    • 7.1.11. Oct 13, 2014: Amedica Announces Unexpected Passing of Former Chairman of the Board Max E. Link, Ph.D.
    • 7.1.12. Oct 07, 2014: Amedica Appoints Eric A. Stookey to the Board of Directors
    • 7.1.13. Sep 30, 2014: Amedica Appoints New President and Chief Executive Officer
    • 7.1.14. Sep 29, 2014: Blue Belt Announces the Addition of Professor David Barrett to Scientific Advisory Board
    • 7.1.15. Sep 29, 2014: Amedica Appoints New Vice President of Business Development
    • 7.1.16. Sep 15, 2014: Wright Medical Group Appoints Kevin D. Cordell as President, U.S. Extremities
  • 7.2. Financial Announcements
    • 7.2.1. Aug 13, 2015: Amedica Reports Second Quarter 2015 Financial Results
    • 7.2.2. Aug 12, 2015: Histogenics Announces Second Quarter 2015 Financial and Operating Results
    • 7.2.3. Jul 29, 2015: Wright Medical Group Reports 2015 Second Quarter Financial Results
    • 7.2.4. Jul 27, 2015: Amedica Announces Preliminary Q2 2015 Financial Results and Update on Recent FDA Response
    • 7.2.5. Jun 23, 2015: Quotient Clinical begins prostate cancer project for Druggability Technologies
    • 7.2.6. May 15, 2015: UPMC Continues Strong Financial Performance Through First Nine Months of Fiscal Year 2015
    • 7.2.7. May 14, 2015: Histogenics Announces First Quarter 2015 Financial Results
    • 7.2.8. May 13, 2015: GenomeDx to present new data in Prostate and Bladder Cancer at the 2015 American Society of Clinical Oncology Annual Meeting
    • 7.2.9. May 07, 2015: Amedica Reports First Quarter 2015 Financial Results
    • 7.2.10. Apr 29, 2015: Wright Medical Group Reports 2015 First Quarter Financial Results
    • 7.2.11. Apr 20, 2015: ALR Technologies Signs First Revenue-Generating Contract
    • 7.2.12. Apr 15, 2015: Tremelimumab granted Orphan Drug Designation by US FDA for treatment of malignant mesothelioma
    • 7.2.13. Mar 05, 2015: Amedica Reports Fourth Quarter and Full Year 2014 Financial Results
    • 7.2.14. Feb 26, 2015: Histogenics Announces Fourth Quarter and Full Year 2014 Financial Results
    • 7.2.15. Feb 25, 2015: Wright Medical Group Reports 2014 Fourth Quarter and Full-Year Financial Results and Provides 2015 Guidance
    • 7.2.16. Jan 20, 2015: Blue Belt Technologies Announces 2014 Results
    • 7.2.17. Jan 12, 2015: Wright Medical Group Announces Preliminary Fourth Quarter and Full Year 2014 Revenue
    • 7.2.18. Dec 18, 2014: Amedica Announces Preliminary Q4 & FY 2014 Financial Results and Update on CASCADE Clinical Study
    • 7.2.19. Dec 04, 2014: Oncolytics Biotech Collaborators Present REOLYSIN and Checkpoint Inhibitor Combination Preclinical Data at AACR Tumor Immunology and Immunotherapy Conference
    • 7.2.20. Nov 06, 2014: Amedica Reports Third Quarter 2014 Financial Results
    • 7.2.21. Nov 06, 2014: Tornier Reports Third Quarter 2014 Results
    • 7.2.22. Nov 05, 2014: Wright Medical Group Reports 2014 Third Quarter Financial Results and Updated Guidance
    • 7.2.23. Oct 27, 2014: Wright Medical Group Announces Third Quarter 2014 Revenue
    • 7.2.24. Sep 22, 2014: VEXIM Announces 2014 Half-year Results
  • 7.3. Legal And Regulatory
    • 7.3.1. Apr 30, 2015: FDA Issues Warning Letter To Smith & Nephew
  • 7.4. Other Significant Developments
    • 7.4.1. Jun 24, 2015: $4.5MM Verdict Reached against Wright Medical Technology says Legal-Bay Lawsuit Settlement Funding
    • 7.4.2. Feb 02, 2015: Smith & Nephew returns as co-sponsor for annual M2D2 competition for entrepreneurial medical device companies
    • 7.4.3. Dec 08, 2014: Data Presented on REVLIMID (lenalidomide) Compared with Investigators' Choice in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
  • 7.5. Product News
    • 7.5.1. Sep 19, 2014: DePuy Synthes Proprietary Variable Angle Locking Technology Now Available To Treat Calcaneal Fractures And Medial Column Fusion Procedures
  • 7.6. Strategy And Business Planning
    • 7.6.1. Jun 17, 2015: Opening of €53.2m DePuy state-of-the-art manufacturing facility
    • 7.6.2. Jun 17, 2015: DePuy Synthes Expands State-of-the-Art Manufacturing Site in Ireland to Support Growing Joint Reconstruction Business
    • 7.6.3. Jan 20, 2015: InterMed Resources and Amedica Announce Agreement With HealthTrust
    • 7.6.4. Jan 12, 2015: Amedica Announces Steps to Simplify Organization and Align Financial Objectives
    • 7.6.5. Sep 22, 2014: Accellent Unveils its New Brand Identity as Lake Region Medical
    • 7.6.6. Sep 10, 2014: Accellent to Close Arvada, CO site and Consolidate Galway, Ireland Operations

8. Appendix

  • 8.1. Research Methodology
    • 8.1.1. Coverage
    • 8.1.2. Secondary Research
    • 8.1.3. Primary Research
    • 8.1.4. Market Modeling and Forecasting
    • 8.1.5. Company Share Analysis
    • 8.1.6. Distribution Share Analysis
  • 8.2. Expert Panel
  • 8.3. GlobalData Consulting
  • 8.4. Contact Us
  • 8.5. Disclaimer

List of Tables

  • Table 1: Shoulder Reconstruction and Small Joints Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 2: Shoulder Reconstruction and Small Joints Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 3: Elbow Replacement Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 4: Shoulder Replacement Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 5: Elbow Replacement Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 6: Shoulder Replacement Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 7: Shoulder Reconstruction and Small Joints Market, United States, Volume (Units), Historic, 2007-2014
  • Table 8: Shoulder Reconstruction and Small Joints Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 9: Elbow Replacement Market, United States, Volume (Units), Historic, 2007-2014
  • Table 10: Shoulder Replacement Market, United States, Volume (Units), Historic, 2007-2014
  • Table 11: Elbow Replacement Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 12: Shoulder Replacement Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 13: Shoulder Reconstruction and Small Joints Market, United States, Average Price ($), Historic, 2007-2014
  • Table 14: Shoulder Reconstruction and Small Joints Market, United States, Average Price ($), Forecast, 2014-2021
  • Table 15: Shoulder Reconstruction and Small Joints Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 16: Shoulder Reconstruction and Small Joints Market, United States, Company Share by Revenue ($m), USD Constant, 2014
  • Table 17: Shoulder Reconstruction and Small Joints Market Pipeline Products
  • Table 18: Hill-Rom to Acquire Welch Allyn for USD2.05 Billion
  • Table 19: Smith & Nephew to Acquire Zimmer Unicompartmental High Flex Knee System Rights in the US
  • Table 20: Histogenics Prices IPO for USD65 Million
  • Table 21: Wright Medical to Merge with Tornier
  • Table 22: Cartiva Raises Additional USD2.5 Million in Series D Financing
  • Table 23: Zyga Raises USD2 Million in Series C-3 Financing
  • Table 24: OrthAlign Raises USD15 Million in Venture Financing
  • Table 25: Blue Belt Secures USD40 Million From CRG
  • Table 26: Zyga Raises USD2 Million in Series D Venture Financing
  • Table 27: Orthopaedic Synergy Raises Additional USD0.9 Million in Venture Financing
  • Table 28: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country

List of Figures

  • Figure 1: Shoulder Reconstruction and Small Joints Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 2: Shoulder Reconstruction and Small Joints Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 3: Elbow Replacement Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 4: Shoulder Replacement Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 5: Elbow Replacement Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 6: Shoulder Replacement Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 7: Shoulder Reconstruction and Small Joints Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 8: Shoulder Reconstruction and Small Joints Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 9: Elbow Replacement Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 10: Shoulder Replacement Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 11: Elbow Replacement Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 12: Shoulder Replacement Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 13: Shoulder Reconstruction and Small Joints Market, United States, Company Share (%) 2014
  • Figure 14: GlobalData Epidemiology-Based Forecasting Model
  • Figure 15: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 16: Primary Interviews by Participant Type (%)
Back to Top